NM_006060.6:c.-15+1616C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006060.6(IKZF1):​c.-15+1616C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.316 in 151,992 control chromosomes in the GnomAD database, including 7,953 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.32 ( 7953 hom., cov: 32)

Consequence

IKZF1
NM_006060.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.06

Publications

17 publications found
Variant links:
Genes affected
IKZF1 (HGNC:13176): (IKAROS family zinc finger 1) This gene encodes a transcription factor that belongs to the family of zinc-finger DNA-binding proteins associated with chromatin remodeling. The expression of this protein is restricted to the fetal and adult hemo-lymphopoietic system, and it functions as a regulator of lymphocyte differentiation. Several alternatively spliced transcript variants encoding different isoforms have been described for this gene. Most isoforms share a common C-terminal domain, which contains two zinc finger motifs that are required for hetero- or homo-dimerization, and for interactions with other proteins. The isoforms, however, differ in the number of N-terminal zinc finger motifs that bind DNA and in nuclear localization signal presence, resulting in members with and without DNA-binding properties. Only a few isoforms contain the requisite three or more N-terminal zinc motifs that confer high affinity binding to a specific core DNA sequence element in the promoters of target genes. The non-DNA-binding isoforms are largely found in the cytoplasm, and are thought to function as dominant-negative factors. Overexpression of some dominant-negative isoforms have been associated with B-cell malignancies, such as acute lymphoblastic leukemia (ALL). [provided by RefSeq, May 2014]
IKZF1 Gene-Disease associations (from GenCC):
  • pancytopenia due to IKZF1 mutations
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Illumina, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • autoimmune disease
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.476 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006060.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IKZF1
NM_006060.6
MANE Select
c.-15+1616C>T
intron
N/ANP_006051.1
IKZF1
NM_001410879.1
c.-15+2008C>T
intron
N/ANP_001397808.1
IKZF1
NM_001220765.3
c.-15+1616C>T
intron
N/ANP_001207694.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IKZF1
ENST00000331340.8
TSL:1 MANE Select
c.-15+1616C>T
intron
N/AENSP00000331614.3
IKZF1
ENST00000359197.9
TSL:1
c.-15+1616C>T
intron
N/AENSP00000352123.5
IKZF1
ENST00000413698.5
TSL:1
c.-15+1616C>T
intron
N/AENSP00000388478.1

Frequencies

GnomAD3 genomes
AF:
0.316
AC:
47941
AN:
151874
Hom.:
7940
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.295
Gnomad AMI
AF:
0.300
Gnomad AMR
AF:
0.432
Gnomad ASJ
AF:
0.237
Gnomad EAS
AF:
0.492
Gnomad SAS
AF:
0.365
Gnomad FIN
AF:
0.272
Gnomad MID
AF:
0.236
Gnomad NFE
AF:
0.297
Gnomad OTH
AF:
0.310
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.316
AC:
47999
AN:
151992
Hom.:
7953
Cov.:
32
AF XY:
0.318
AC XY:
23635
AN XY:
74288
show subpopulations
African (AFR)
AF:
0.295
AC:
12228
AN:
41420
American (AMR)
AF:
0.433
AC:
6611
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.237
AC:
821
AN:
3468
East Asian (EAS)
AF:
0.492
AC:
2540
AN:
5164
South Asian (SAS)
AF:
0.367
AC:
1770
AN:
4826
European-Finnish (FIN)
AF:
0.272
AC:
2866
AN:
10556
Middle Eastern (MID)
AF:
0.240
AC:
70
AN:
292
European-Non Finnish (NFE)
AF:
0.297
AC:
20158
AN:
67964
Other (OTH)
AF:
0.314
AC:
663
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1674
3348
5022
6696
8370
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
476
952
1428
1904
2380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.306
Hom.:
22873
Bravo
AF:
0.324

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.61
DANN
Benign
0.46
PhyloP100
-2.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7781977; hg19: chr7-50346134; API